David Bautz
Analyst-Equity bij Zacks Investment Research, Inc. (Small Cap Research)
Profiel
Dr. David Bautz is a Senior Biotechnology Analyst at Zacks Investment Research, Inc. He joined the firm in February 2014.
Dr. Bautz worked for two years as a Research Associate at Human Genome Sciences, Inc., a biotechnology company that was eventually acquired by GlaxoSmithKline.
He obtained his PhD in Biochemistry and Biophysics from the University of North Carolina at Chapel Hill in 2008.
His dissertation research focused on the characterization of autoantibodies in patients suffering from an orphan autoimmune disease.
He obtained his BS and MS degrees in Biochemistry from Virginia Tech.
Actieve functies van David Bautz
| Bedrijven | Functie | Begin |
|---|---|---|
| Zacks Investment Research, Inc. (Small Cap Research) | Analyst-Equity | 01-02-2014 |
Opleiding van David Bautz
| The University of North Carolina at Chapel Hill | Doctorate Degree |
| Virginia Polytechnic Institute & State University | Graduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 1 |
|---|---|
| Zacks Investment Research, Inc. (Small Cap Research) | Finance |
